Chemed (NYSE:CHE) Director Andrea Lindell Sells 1,347 Shares of Stock

Posted by Francis Steltz on Jun 11th, 2026

Chemed Corporation (NYSE:CHE – Get Free Report) Director Andrea Lindell sold 1,347 shares of the business’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Chemed Stock Performance

Shares of NYSE CHE opened at $434.63 on Thursday. The company has a market cap of $5.77 billion, a PE ratio of 23.69, a P/E/G ratio of 1.67 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $562.77. The stock has a 50 day simple moving average of $413.56 and a 200-day simple moving average of $424.69.

Chemed (NYSE:CHE – Get Free Report) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The firm had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities research analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Thursday, May 28th. Chemed’s dividend payout ratio is 13.08%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Maripau Wealth Management LLC increased its holdings in shares of Chemed by 5.4% in the first quarter. Maripau Wealth Management LLC now owns 970 shares of the company’s stock valued at $366,000 after buying an additional 50 shares in the last quarter. Segall Bryant & Hamill LLC acquired a new stake in Chemed during the 1st quarter valued at $2,293,000. Cim LLC raised its stake in Chemed by 1.6% during the 1st quarter. Cim LLC now owns 2,325 shares of the company’s stock valued at $878,000 after purchasing an additional 37 shares during the period. Amundi raised its stake in Chemed by 6,982.7% during the 1st quarter. Amundi now owns 35,555 shares of the company’s stock valued at $13,431,000 after purchasing an additional 35,053 shares during the period. Finally, EverSource Wealth Advisors LLC raised its stake in Chemed by 9.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock valued at $153,000 after purchasing an additional 35 shares during the period. Institutional investors own 95.85% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Oppenheimer dropped their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Royal Bank Of Canada upped their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a report on Monday. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, Chemed has an average rating of “Hold” and an average price target of $501.50.

Get Our Latest Stock Report on CHE

About Chemed

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.